Most common cosmetic procedures: 67 med spa statistics for 2026
Neuromodulator injections top the list at 9.88 million US procedures a year, in ...
Last Updated: August 10, 2026
Key takeaways
Americans have 28,243,407 minimally invasive cosmetic procedures a year, led by 9.88 million neuromodulator treatments.
US non-surgical aesthetic spending has reached $20.5 billion, growing 5% in a single year.
Neurotoxins capture 32% of every non-surgical dollar, the largest share of any treatment category.
Weight-loss treatments grew from 2% to 12% of aesthetic spend in just three years.
The median med spa books only 38% of available staff hours, so operations decide profit more than the treatment menu.
Cosmetic treatments and injectables are part of a rapidly growing market. Neuromodulator injections such as Botox are the most common cosmetic procedures in the US, at 9,883,711 treatments a year1. In total, Americans now have 28,243,407 minimally invasive procedures annually and spend $20.5 billion on non-surgical treatments1, 4.
Below, we rank the most popular cosmetic procedures and pair each treatment’s volume with what it earns per visit and per year. If you run a med spa, you won’t be surprised to learn that the most common procedures are rarely the highest earners. Some of the busiest treatments earn the least per appointment, and one former bestseller is collapsing outright.
These medical spa statistics come from national procedure counts, audited financial filings and measured point-of-sale data. Prices come straight from published med spa price lists, so every figure reflects what patients pay today.
Volume and value do not line up
Annual US procedure volume against the average physician fee per procedure. Bubble area is the category’s annual value (volume × fee). Only four categories have a published average fee, so only four are plotted.
$0
$500
$1,000
$1,500
$2,000
$2,500
1Neuromodulator injectionsVolume 9,883,711 procedures a year
Average physician fee $435
9,883,711 × $435 = $4.30bn category value
Average physician fee $435
9,883,711 × $435 = $4.30bn category value
2Hyaluronic acid dermal fillersVolume 5,331,426 procedures a year
Average physician fee $715
5,331,426 × $715 = $3.81bn category value
Average physician fee $715
5,331,426 × $715 = $3.81bn category value
3Combination laser treatmentsVolume 3,112,056 procedures a year
Average physician fee $697
3,112,056 × $697 = $2.17bn category value
Average physician fee $697
3,112,056 × $697 = $2.17bn category value
4Nonsurgical skin tighteningVolume 439,032 procedures a year
Average physician fee $2326
439,032 × $2326 = $1.02bn category value
Average physician fee $2326
439,032 × $2326 = $1.02bn category value
Neuromodulators$4.30bn a year
HA fillers$3.81bn a year
Combination lasers$2.17bn a year
Skin tightening$1.02bn a year
02M4M6M8M10M12MLowest volume,
highest price per visit.
highest price per visit.
Highest volume,
lowest price per visit.
lowest price per visit.
Annual procedures →
1Neuromodulators — 9,883,711 procedures at $435 each, $4.30bn a year2HA fillers — 5,331,426 procedures at $715 each, $3.81bn a year3Combination lasers — 3,112,056 procedures at $697 each, $2.17bn a year4Skin tightening — 439,032 procedures at $2326 each, $1.02bn a year
The dashed curve marks equal category value of $2.0bn a year. Skin tightening earns 5.3× more per procedure than a neuromodulator treatment, on 4% of the volume.
Source: ASPS 2024 Procedural Statistics (volumes, source 1) and ASPS average physician fees (source 2). Category value is volume × average fee, for example 9,883,711 × $435 = $4.30bn. Vertical axis is the physician fee only, not total patient spend.
67 Cosmetic procedure statistics and facts at a glance
Most popular procedures12 stats128.2 million minimally invasive procedures happen in the US each year2Neuromodulators top the list at 9.88 million treatments3HA fillers follow in second place with 5.33 million4Skin resurfacing accounts for 3.7 million treatments5Combination laser work totals 3.11 million procedures6HA lip augmentation enters the count at 1.59 million7Other injectable lip treatments add 1.45 million more8Sculptra, Radiesse and other non-HA fillers reach 932,8619Prescribed weight-loss medication joins the ranking at 837,48510Sclerotherapy stays flat at 516,883 treatments11Noninvasive fat reduction drops 40% to 447,58112Nonsurgical skin tightening rounds out the list at 439,032Med spa market size6 stats13Non-surgical aesthetics is a $20.5 billion market in the US14Over 11,000 med spas are open across the country15The industry supports more than 100,000 jobs1681% of practices run from a single location17Two thirds of single-owner med spas have no physician owner1874% of medical directors trained outside core aesthetic specialtiesBotox facts7 stats19A neurotoxin brings in 34% of all first-time visits20Roughly 40% of new Botox patients rebook inside six months21The typical Botox patient comes in twice a year22Botox is where most Gen Z patients start23Women make up 89% of the med spa patient base24Around one in 10 patients is male25Combined Botox and filler visits slid from 20% to 13%Botox pricing4 stats26Published price lists put Botox at $10.00 to $12.95 a unit27Twenty units come to about $219, and 30 units to $32928The average physician fee per neuromodulator treatment is $43529Dysport lists near $4 a unit next to Botox’s $10Botox market share4 stats30Neurotoxins take 32% of every non-surgical dollar31The US neurotoxin market runs to about $4.3 billion a year32Botox’s US revenue fell 10.5% as Jeuveau gained 11.6%33Alle counts 8 million members across 30,000 US practicesLaser hair removal7 stats34Small areas run $29–$150, and medium areas $50–$25035A Brazilian session lands between $65 and $22536Most patients book 6–8 sessions, 4–12 weeks apart37Six-session packages save 15–35%, then maintenance runs $75–$35038Physicians charge $697 on average for laser treatments39No treatment brings patients back more often40Laser work adds up to 3.1 million procedures and $2.2 billionDermal fillers7 stats41Fillers claim 20% of US non-surgical spending42The average HA filler visit is worth $91043Biostimulator visits average closer to $1,28044The filler market is worth roughly $3.8 billion a year45Med spas list a syringe at $549–$59946Juvederm’s US revenue dropped 18% in 202547Lip procedures pass 3 million a yearMedical weight loss7 stats48Weight loss went from 2% to 12% of aesthetic spend in three years49Roughly 40% of GLP-1 patients have never visited the practice before5046% of weight-loss patients come back, second only to injectables51By early 2025, 60% of med spas offered GLP-1 against 35% of physician offices52The service adds $15,000–$20,000 in monthly sales53Practices selling GLP-1 grew revenue 9% while the rest fell 2%54Compounded semaglutide runs $250–$375 a month, under branded self-payTrends to watch7 stats55Gen Z grew from 4% to 10% of aesthetic patients in seven years56Gen Z patients average 2.75 visits a year57Body contouring spend has halved since its peak58Biostimulators gained 11% as HA fillers lost the same59Device sales fell 30% in two years, but consumables kept growing60Hydrafacial accounts for about 7% of new med spa patients61Polynucleotide bookings average $210 and rose 23% in a yearMed spa revenue6 stats62The median location earns $1.86 million, and the top 10% clear $4.25 million63A median transaction is $216, against $484 at the 90th percentile64Median utilization is 38% of staff hours, while leaders hit 80%65Just 13% of bookings come through online, the lowest in beauty66Members retain 88% better and book three times as often67Retail skincare adds $174 a visit and lifts total spend by half
The history of injectable treatments: A timeline
Injectables dominate any list of statistics on Botox and fillers today, yet the first approval only landed in 1981. The milestones below trace how a niche medical product became a 28-million-procedure industry3.
Every US injectable milestone since 1981
Every milestone sits at its true position on the year axis, with a leader line out to an evenly spaced label. Marker shape carries the product type, so color is never doing the work alone. A dashed marker means the FDA has not cleared that product yet.
NeurotoxinFillerBiostimulatorOtherIn FDA review
- 1981 — Zyderm collagen. The first injectable dermal filler.
- 1989 — Oculinum. Botulinum toxin type A, for eye-muscle disorders.
- 2002 — Botox Cosmetic. Approved for frown lines, opening the modern injectables era.
- 2003 — Restylane. The first hyaluronic acid filler approved in the US.
- 2004 — Sculptra. The first poly-L-lactic acid biostimulator.
- 2006 — Juvederm, Radiesse. Both receive FDA approval.
- 2009 — Dysport. The second cosmetic neurotoxin on the US market.
- 2011 — Xeomin. Approved for glabellar lines.
- 2015 — Kybella. The first injectable approved to dissolve chin fat.
- 2019 — Jeuveau. The first US neurotoxin approved solely for aesthetics.
- 2022 — Daxxify. The first long-acting, peptide-formulated neurotoxin.
- 2024 — Weight-loss injections. Enter the national count at 837,485 treatments.
- 2025 — Evolysse Form and Smooth. The first cold-processed hyaluronic acid fillers.
- 2026 — Skinvive for the neck. The first filler approved for horizontal neck lines.
- Next — Two next-generation neurotoxins still waiting on FDA clearance.
2002 opened the modern injectables era. 2024 brought weight-loss injections into the national count, at 837,485 treatments. 2026 took fillers below the jaw for the first time.
Sources: FDA approval dates (source 3), ASPS 2024 Procedural Statistics (source 1), and company regulatory announcements (source 24). The timeline reflows to a vertical list on narrow screens rather than shrinking the type.
- 1981 — The FDA approves bovine collagen (Zyderm), the first injectable dermal filler.
- 1989 — Botulinum toxin type A is approved as Oculinum for eye-muscle disorders.
- 2002 — Botox Cosmetic is approved for frown lines, opening the modern injectables era.
- 2003 — Restylane becomes the first hyaluronic acid filler approved in the US.
- 2004 — Sculptra, the first poly-L-lactic acid biostimulator, wins FDA approval.
- 2006 — Juvederm and Radiesse both receive FDA approval.
- 2009 — Dysport becomes the second cosmetic neurotoxin on the US market.
- 2011 — Xeomin is approved for glabellar lines.
- 2015 — Kybella becomes the first injectable approved to dissolve chin fat.
- 2019 — Jeuveau launches as the first US neurotoxin approved solely for aesthetics.
- 2022 — Daxxify brings the first long-acting, peptide-formulated neurotoxin to market.
- 2024 — Prescribed weight-loss injections enter the national cosmetic procedure count for the first time, at 837,485 treatments1.
- 2025 — Evolysse Form and Smooth win approval, the first hyaluronic acid fillers made by cold processing3.
- 2026 — Skinvive by Juvederm becomes the first filler approved for horizontal neck lines3.
- Next — Two next-generation neurotoxins wait on US clearance. The FDA asked both makers about manufacturing, not about safety or trial data24.
Every statistic below sits in one of 10 sections. Use the list to jump straight to the number you need, or read on for the full picture.
Most popular cosmetic procedures
The most popular cosmetic procedures in the US are neuromodulator injections, hyaluronic acid fillers, skin resurfacing, and combination laser treatments1. The full ranking of the most popular aesthetic treatments comes from ASPS statistics, the only national per-procedure volume count.
However, there’s a caveat to these numbers. ASPS surveys over 5,000 board-certified plastic surgeons and extrapolates from almost 1,000 responses1. Nurse-owned med spas sit outside that sample, so the most popular med spa treatments run at even higher volumes than plastic surgery statistics suggest.
| Rank | Procedure | Procedures per year | Annual change |
|---|---|---|---|
| 1 | Neuromodulator injections | 9,883,711 | +4% |
| 2 | Hyaluronic acid fillers | 5,331,426 | +1% |
| 3 | Skin resurfacing | 3,703,305 | +6% |
| 4 | Combination laser treatments | 3,112,056 | 0% |
| 5 | HA lip augmentation | 1,589,502 | New category |
| 6 | Lip augmentation, injectable materials | 1,449,565 | +1% |
| 7 | Non-HA fillers | 932,861 | +1% |
| 8 | Prescribed weight-loss medication | 837,485 | New category |
| 9 | Sclerotherapy | 516,883 | 0% |
| 10 | Noninvasive fat reduction | 447,581 | -40% |
| 11 | Nonsurgical skin tightening | 439,032 | 0% |
The 11 most common cosmetic procedures in the US
Procedures performed per year, ranked. The right-hand column carries the change on the year, with the sign doing the work and color only reinforcing it.
1. Neuromodulator injections
9,883,711
+4%
Neuromodulator injectionsRank 1 of 119,883,711 procedures a year
Year over year: +4%
2. Hyaluronic acid fillers
5,331,426
+1%
Hyaluronic acid fillersRank 2 of 115,331,426 procedures a year
Year over year: +1%
3. Skin resurfacing
3,703,305
+6%
Skin resurfacingRank 3 of 113,703,305 procedures a year
Year over year: +6%
4. Combination laser treatments
3,112,056
0%
Combination laser treatmentsRank 4 of 113,112,056 procedures a year
Year over year: 0%
5. HA lip augmentation †
1,589,502
New
HA lip augmentationRank 5 of 111,589,502 procedures a year
Year over year: new category
New category in the 2024 count
6. Lip augmentation, injectable materials †
1,449,565
+1%
Lip augmentation, injectable materialsRank 6 of 111,449,565 procedures a year
Year over year: +1%
7. Non-HA fillers
932,861
+1%
Non-HA fillersRank 7 of 11932,861 procedures a year
Year over year: +1%
8. Prescribed weight-loss medication
837,485
New
Prescribed weight-loss medicationRank 8 of 11837,485 procedures a year
Year over year: new category
New category in the 2024 count
9. Sclerotherapy
516,883
0%
SclerotherapyRank 9 of 11516,883 procedures a year
Year over year: 0%
10. Noninvasive fat reduction
447,581
−40%
Noninvasive fat reductionRank 10 of 11447,581 procedures a year
Year over year: -40%
745,967 → 447,581 procedures
11. Nonsurgical skin tightening
439,032
0%
Nonsurgical skin tighteningRank 11 of 11439,032 procedures a year
Year over year: 0%
02M4M6M8M10M
† The two lip rows are counted separately to avoid double counting. Together they represent over 3 million lip procedures a year.
Source: ASPS 2024 Procedural Statistics (source 1). Two categories entered the count in 2024 and have no year-over-year change, so they are marked New rather than shown as 0% growth.
1. Americans have 28,243,407 minimally invasive cosmetic procedures a year
Americans have 28,243,407 minimally invasive cosmetic procedures a year across all tracked categories1. Comparable categories grew 1.5% year over year, and two newly tracked categories added 2.4 million procedures on top.
For scale, plastic surgery statistics count fewer than 1.6 million cosmetic surgeries a year1. Non-surgical treatments outnumber surgery roughly 17 to one, which is why the med spa now defines the industry.
Non-surgical treatments outnumber surgery 17 to one
One square is one million procedures a year. The count itself is the encoding, so both rows share a single color and are told apart by their labels.
17 to 1minimally invasive procedures for every
cosmetic surgery performed in the US
cosmetic surgery performed in the US
Minimally invasive procedures 28,243,407 a year
Cosmetic surgeries fewer than 1,600,000 a year
Source: ASPS 2024 Procedural Statistics (source 1). ASPS surveys over 5,000 board-certified plastic surgeons. Nurse-owned med spas sit outside that sample, so med spa volumes run higher than this count shows.
2. Neuromodulator injections rank #1 with 9,883,711 procedures
Neuromodulator injections rank first among the most popular cosmetic treatments, at 9,883,711 procedures a year, up 4%1. The category covers Botox, Dysport, Xeomin, Jeuveau and Daxxify.
That is 1.9 times the volume of the next treatment. Toxins are the front door of the entire industry, which the retention data later in this ranking confirms.
3. Hyaluronic acid fillers rank #2 with 5,331,426 procedures
Hyaluronic acid fillers rank second at 5,331,426 procedures a year, up 1%1. However, the steady count hides falling spend. US revenue for the leading filler brand dropped 18% in 202514.
4. Skin resurfacing treatments reach 3,703,305 procedures
Skin resurfacing treatments total 3,703,305 procedures a year, combining chemical peels, microdermabrasion, and laser resurfacing1. At 6% growth, resurfacing is the fastest riser among the top four categories.
5. Combination laser treatments total 3,112,056 procedures
Combination laser treatments account for 3,112,056 procedures a year, bundling laser hair removal, IPL, tattoo removal, and leg-vein work1. Laser hair removal drives the bucket and generates more return visits than any other med spa service8.
6. HA lip augmentation debuts in the count at 1,589,502 procedures
Hyaluronic acid lip augmentation entered the national count as its own category at 1,589,502 procedures1. A brand-new tracked category landing fifth overall says a lot about where patient demand sits.
7. Lip augmentation with injectable materials adds 1,449,565 procedures
Lip augmentation with other injectable materials adds 1,449,565 procedures a year, up 1%1. It is counted separately from the HA row above to avoid double counting. Read side by side, the two rows make lips one of the busiest treatment areas in US aesthetics.
8. Non-HA fillers such as Sculptra and Radiesse hit 932,861 procedures
Non-HA fillers such as Sculptra and Radiesse reach 932,861 procedures a year1. Biostimulators run at a sixth of HA filler volume but earn more per visit, as the filler section below shows.
9. Prescribed weight-loss medication enters the ranking at 837,485 procedures
Prescribed weight-loss medication entered the national count at 837,485 procedures1. No treatment has ever joined the ranking this high. GLP-1 programs reshaped the med spa menu faster than any device or injectable before them, as you can see in our list of GLP-1 statistics.
10. Sclerotherapy holds steady at 516,883 procedures
Sclerotherapy holds steady at 516,883 spider-vein procedures a year1. It is a quiet workhorse. Patients need three to six treatments spaced about a month apart, so one patient reliably becomes a season of appointments23.
11. Noninvasive fat reduction collapses 40% to 447,581 procedures
Noninvasive fat reduction fell 40% in a single year, to 447,581 procedures from 745,9671. That is the steepest decline in the ranking. GLP-1 medication is absorbing body-contouring demand outright rather than complementing it.
12. Nonsurgical skin tightening closes the list at 439,032 procedures
One category is collapsing, the rest are holding
Change in annual procedure volume, most positive to most negative. Every bar carries its signed value, so direction is readable without relying on color.
Skin resurfacing
+6%
Fastest-growing tracked category
Neuromodulator injections
+4%
Growth on the largest base on the list
Hyaluronic acid fillers
+1%
Lip augmentation, injectable materials
+1%
Non-HA fillers
+1%
Combination laser treatments
0%
Flat on the year
Sclerotherapy
0%
Flat on the year
Nonsurgical skin tightening
0%
Flat on the year
Noninvasive fat reduction
−40%
Nearly 300,000 procedures lost in one year
Noninvasive fat reduction fell from 745,967 to 447,581 procedures. GLP-1 medication is absorbing body-contouring demand, and the collapse is 6.7× the size of the biggest gain on the list.
New in 2024 HA lip augmentation 1,589,502New in 2024 Prescribed weight-loss medication 837,485
Source: ASPS 2024 Procedural Statistics (source 1). The two categories that entered the count in 2024 have no prior year to compare against. They sit outside the bars rather than being shown as growth. The axis is not broken or compressed.
Nonsurgical skin tightening closes the ranking at 439,032 procedures a year, flat year over year1. It compensates with price. At $2,326, it carries the highest average physician fee of any minimally invasive procedure2.
Med spa market size
The US med spa market size stands at $20.5 billion in annual non-surgical spending, measured at the point of sale4. The medical spa industry statistics below cover locations, employment, and who owns the industry.
13. US non-surgical aesthetic spending reaches $20.5 billion
Where the $20.5 billion goes
Share of US non-surgical aesthetic patient spending, measured at the point of sale.
$20.5bnUS non-surgical aesthetic spending,
up 5% on the year
up 5% on the year
32%Neurotoxins32% of US non-surgical patient spending
About $6.6bn of the $20.5bn total
Source 4
About $6.6bn of the $20.5bn total
Source 4
20%Dermal fillers20% of US non-surgical patient spending
About $4.1bn of the $20.5bn total
Source 5
About $4.1bn of the $20.5bn total
Source 5
12%Weight-loss treatments12% of US non-surgical patient spending
About $2.5bn of the $20.5bn total
Source 6
About $2.5bn of the $20.5bn total
Source 6
36%All other categories36% of US non-surgical patient spending
About $7.4bn of the $20.5bn total
Residual: total minus the three named shares
About $7.4bn of the $20.5bn total
Residual: total minus the three named shares
Neurotoxins 32%Dermal fillers 20%Weight-loss treatments 12%All other categories 36%
Weight-loss treatments were 2% of spend three years ago. No other category on this bar has moved that far, that fast.
Sources: market size and growth (source 4), neurotoxin and filler shares (source 5), weight-loss share (source 6). The 36% remainder is arithmetic rather than a published figure. It is the total minus the three named shares, and the article does not break it down. Point-of-sale spend is not manufacturer revenue.
US non-surgical aesthetic spending reaches $20.5 billion a year, up 5% year over year4. The figure comes from point-of-sale transactions across thousands of practices, so it measures dollars spent rather than surveyed estimates. That makes it the strongest medical spa market size figure available.
14. More than 11,000 med spas operate in the United States
Med spa locations keep opening
Number of med spas operating in the US. The source describes these as the current year and the two before it, without naming them. The axis is relative, and no years are stamped on it.
8,899Two years ago8,899 med spa locations
10,488Last year10,488 med spa locations
11,000+Now11,000+ med spa locations
An open-ended floor: the source says more than 11,000
An open-ended floor: the source says more than 11,000
Two years ago
Last year
Now
The current figure is an open-ended floor, which is why the third column fades out at the top rather than stopping at a hard 11,000. Several new locations open every day.
Industry employees 100,000+Which is about 9 to 10 people per practice
Source: AmSpa industry counts (source 11). The article gives no explicit years for these three figures, so none are invented here. The per-practice headcount is derived: 100,000+ employees divided by 11,000+ locations.
More than 11,000 med spas operate in the US, according to AmSpa statistics, up from 10,488 the year before and 8,899 the year before that11. At that pace of medical spa industry growth, several new locations open every day.
15. The med spa industry employs more than 100,000 people
The med spa industry employs more than 100,000 people11. Spread across 11,000 locations, that works out to roughly nine or ten people per practice. For all its billion-dollar headlines, this remains a small-business industry.
16. 81% of med spas are single-location businesses
81% of med spas are single-location businesses, and just 3% are private-equity owned11. Despite the consolidation headlines, medspa statistics still describe an owner-operator industry.
17. 67% of single-owner med spas are not owned by a physician
67% of single-owner med spas are not owned by a physician or surgeon11. Nurse practitioners, registered nurses, and non-medical entrepreneurs own two-thirds of them. It also explains why surgeon-survey procedure counts undercount med spa volume.
18. 74% of med spa medical directors come from outside core aesthetic specialties
Who owns and staffs the med spa industry
Four unrelated percentages, shown as figures rather than as a chart. Putting them in one bar chart would imply a comparison that does not exist.
81%
of med spas are single-location businesses
Independent ownership still defines the industry.
3%
are private-equity owned
Consolidation is real but small so far.
67%
of single-owner med spas are not physician-owned
Nurses and other operators own most of them.
74%
of medical directors trained outside plastic surgery or dermatology
The supervising physician is usually from another specialty.
Patient mix inside med spas
89%
of med spa patients are women
Roughly one patient in ten is a man.
54%
of female patients are aged 35 to 54
The core demographic of the treatment room.
Source: AmSpa 2024 industry data (source 11). The patient-mix figures describe who walks into a med spa. They are not the share of American women who get Botox, which is a different measure entirely. The meters show each figure in isolation and are not four series of one chart.
74% of med spa medical directors trained in fields other than plastic surgery or dermatology11. Among the more surprising med spa facts, this one carries real compliance weight, since medical director rules vary sharply by state.
Botox facts
The Botox facts below cover how patients find, use, and return for neurotoxin treatments. Two units matter here. Procedure counts are not people, and patient-mix percentages are not population percentages.
19. 34% of all first-time non-surgical visits are for a neurotoxin
34% of all first-time non-surgical aesthetic visits are for a neurotoxin7. One in three new patients walks in for Botox or a rival toxin before trying anything else. Whatever a med spa sells, toxins are how patients arrive.
20. About 40% of first-time Botox patients return within 6 months
About 40% of first-time Botox patients return within six months, and about half return within a year7, 10. Among botox usage statistics, this is the one that defines the business model. Neurotoxins are the industry’s primary driver of repeat visits.
21. The average Botox patient books 2 appointments per year
How Botox patients arrive, and whether they come back
Two different measures, kept in two labeled groups. The arrival figure is a share of visits; the return figures are retention of first-time patients, so they must not be multiplied together.
~5 millionAmericans get Botox in a year
9,883,711 procedures ÷ 2 visits each
9,883,711 procedures ÷ 2 visits each
How patients arrive
Share of first-time non-surgical visits
34%
The single most common way a patient enters a med spa
Whether they come back
Return within 6 months
~40%
Return within 12 months
~50%
0%25%50%75%100%
Appointments per Botox patient per year 2Same-visit Botox-plus-filler bookings 20% → 13% since 2018
Sources: procedure volume (source 1), first-visit share (source 7), retention (source 10), visit frequency and combination bookings (source 13). The headline is derived: 9,883,711 procedures divided by 2 visits per patient per year. Retention percentages describe first-time patients only.
The average Botox patient books two appointments a year13. That ratio answers how many people get Botox a year honestly. Divide 9.88 million procedures by two visits each, and roughly 5 million Americans get Botox annually1, 13.
22. Botox is the #1 first treatment for Gen Z patients
Botox is the number one first treatment for Gen Z patients, ahead of laser hair removal, Dysport, Hydrafacial, and aesthetician services8. Younger patients now skip the low-commitment starter services and go straight to injectables.
23. 89% of med spa patients are women
89% of med spa patients are women, and 54% of female patients are aged 35 to 5411. Note the unit. This is the patient mix inside med spas, not the percentage of American women who get Botox.
24. Roughly 1 in 10 med spa patients is a man
Roughly one in 10 med spa patients is a man, derived from the 89% female mix11. That covers all med spa services. Nobody publishes male Botox statistics as a separate national count, so treat any precise figure with suspicion.
25. Same-visit Botox-plus-filler appointments fell from 20% to 13%
Same-visit Botox-plus-filler appointments fell from 20% to 13% of injectable visits since 20187. The classic injectable cross-sell is quietly shrinking even as toxin volume grows. Patients are choosing one product, and it is usually the toxin.
How much does Botox cost on average?
Botox costs $10.00 to $12.95 per unit at published US med spa price lists23. The average cost of Botox as a full treatment is $4352. The figures below come from 13 practices across eight metros plus the national fee benchmark.
26. Botox costs $10.00 to $12.95 per unit at published price lists
Botox costs $10.00 to $12.95 per unit at published med spa price lists, with first-time-client rates starting around $10.9523. Per-unit pricing dominates because total cost scales with dose, which varies by patient and treatment area.
27. A 20-unit Botox treatment runs about $219, and 30 units about $329
A 20-unit Botox treatment runs about $219, 30 units about $329, and 40 units about $438 at published fixed-package prices23. If you are researching average Botox units, fixed packages translate the question into dollars, which is what the decision comes down to.
28. The average physician fee for a neuromodulator treatment is $435
The average physician fee for a neuromodulator treatment is $435, the most recent per-procedure average published nationally2. Sitting above the street packages, it suggests a typical full treatment lands between 30 and 40 units.
29. Dysport sells for about $4 per unit against Botox’s $10
The Botox price ladder, and the Dysport unit trap
Two separate questions on two separate axes: what a treatment costs, and what a unit costs. Price per unit and price per treatment never share a scale.
What a Botox treatment costs
Published package prices, per treatment
$21920 unitsPublished package price $219
Works out at $10.95 per unit
Works out at $10.95 per unit
$32930 unitsPublished package price $329
Works out at $10.97 per unit
Works out at $10.97 per unit
$43840 unitsPublished package price $438
Works out at $10.95 per unit
Works out at $10.95 per unit
National average fee $435
20 units
30 units
40 units
The ASPS national average fee lands between the 30-unit and 40-unit packages. That is how a typical treatment is inferred to be 30 to 40 units.
Botox against Dysport, per unit
Price per unit is not a like-for-like comparison
Step 1 — the common mistake
Botox
$10
Dysport
$4
Looks 60% cheaper, but the unit is smaller
Step 2 — dose-equivalent
Botox
$10
Dysport
$10–$12
$4 × 2.5–3 = $10–$12 of Dysport per Botox unit
Once the dose is equalized, Dysport costs the same as Botox or slightly more.
Sources: published med spa price lists (source 23), ASPS average physician fee (source 2), manufacturer unit pricing (source 22). Botox runs $10.00 to $12.95 per unit at published price lists, with first-time rates from $10.95.
Dysport sells for about $4 per unit against Botox’s $10, because the units are not the same21, 23. Dysport doses at roughly 2.5 to 3 units per Botox unit. Comparing the two per-unit prices head-to-head is the most common Botox pricing mistake.
Botox market share
Botox market share statistics tell the money side of the toxin story. The category dominates spending, but the brands inside it are trading places.
30. Neurotoxins capture 32% of all US non-surgical patient spending
Neurotoxins capture 32% of all US non-surgical patient spending, the largest single category, measured from point-of-sale transactions5. Nearly one dollar in three spent at a med spa goes to a toxin.
31. The US neurotoxin market is worth about $4.3 billion a year
The US neurotoxin market is worth about $4.3 billion a year in patient spending. The arithmetic is simple: 9,883,711 procedures multiplied by the $435 average fee equals $4.30 billion1, 2. That answers the Botox market size question at treatment prices rather than wholesale drug prices.
32. Botox’s maker lost 10.5% of US revenue while challenger Jeuveau grew 11.6%
Demand is up, the incumbent is down
Percent change on the year for one volume measure and three revenue lines. Revenue levels sit in the labels as text, never on a second axis.
Jeuveau US revenue
$297m
$297m
+11.6%
Up 11.6% on the year
Growing from a base about one-fifth of AbbVie’s
US neurotoxin procedures
9,883,711
9,883,711
+4%
Up 4% on the year
Demand is not the problem
Botox Cosmetic US revenue
$1.50bn
$1.50bn
−10.5%
Down 10.5% on the year
US Juvederm revenue
Down 26% in two years
Down 26% in two years
−18%
Down 26% across two years
The article’s most decisive filler datapoint
Toxin demand is holding firm. Brand share is moving to cheaper challengers.
Sources: procedure volume (source 1), AbbVie reported US revenue (source 14), Evolus reported US revenue (source 15). Note the scale asymmetry: Evolus grew 11.6% on a base roughly one-fifth the size of AbbVie’s, so the challenger has not caught up. Procedure counts and revenue are different units.
Botox’s maker lost 10.5% of US Botox Cosmetic revenue in 2025, falling to $1.50 billion, while challenger Evolus grew 11.6% to $297 million14, 15. Procedure counts rose 4% over the same stretch1. Toxin demand is holding firm while brand share moves to cheaper challengers.
33. The Alle loyalty program counts 8 million members across 30,000 US practices
The Alle loyalty program counts 8 million members across 30,000 US practices18. Injectables have become a loyalty-program product, which explains why retention statistics dominate every serious conversation about botox trends.
Laser hair removal cost average
The laser hair removal cost average runs $29 to $150 per session for small areas and $50 to $250 for medium areas23. Every price below is a first-party figure from 13 practices across eight US metros.
34. Laser hair removal costs $29–$150 for small areas and $50–$250 for medium areas
Laser hair removal costs $29 to $150 per session for small areas like the upper lip, and $50 to $250 for medium areas23. Large areas run $142 to $400, and full-body sessions span $399 to $2,000. That is the typical cost of laser hair removal at published US price lists.
35. A Brazilian laser hair removal session averages $65–$225
What one laser hair removal session costs
Published per-session price ranges by treatment area, lowest price first. Both endpoints are labeled, because a range without its numbers says nothing.
Single areas — axis runs to $400
Small, e.g. upper lip
$29$150
13 practices across eight US metros
Medium
$50$250
13 practices across eight US metros
Brazilian
$65$225
Miami $135–$200 · Denver from $65 · Boston $115
Large
$142$400
13 practices across eight US metros
$0$100$200$300$400
Full body — a different axis, running to $2,000
Full body
$399$2,000
13 practices across eight US metros
$0$500$1,000$1,500$2,000
After the first course — maintenance, not a first-course session
Post-package maintenance
$75$350
Charged after a completed package
Full body tops out at 13× the high end of a small area. It sits on its own axis rather than compressing everything else. Neither axis is broken or logarithmic.
Source: published price lists from 13 practices across eight US metros (source 23). Most patients need 6 to 8 sessions spaced 4 to 12 weeks apart, and some areas take 10 to 12. Six-session packages discount 15% to 35%.
A Brazilian laser hair removal session averages $65 to $225, depending on the city23. Miami practices publish $135 to $200 per session, Denver starts at $65, and Boston lists $115.
36. Most patients need 6–8 sessions, spaced 4–12 weeks apart
Most patients need six to eight laser hair removal sessions, spaced four to 12 weeks apart, and some areas take 10 to 1223. Sessions run five minutes for an upper lip to about an hour for full legs. One buying decision turns into a year of visits.
37. Six-session packages discount 15–35%, then maintenance runs $75–$350 per session
Six-session packages discount 15% to 35% off single-session prices, and post-package maintenance runs $75 to $350 per session23. The package-plus-maintenance structure is exactly why this service generates more return visits than anything else on the menu.
38. The average physician fee for laser treatments is $697
The average physician fee for laser treatments is $697, blended across the combination laser category2. It sits well above single-session street prices because it also covers pricier laser work like tattoo removal and leg veins.
39. Laser hair removal is the #1 treatment by visit frequency
Laser hair removal is the number one med spa treatment by visit frequency, generating the most return visits of any service8. It also ranks second, after Botox, as the first treatment Gen Z patients book. High frequency does not mean high spend, though — per dollar, it ranks behind toxins.
40. Laser treatments account for 3.1 million procedures and about $2.2 billion a year
Laser treatments account for 3,112,056 procedures and roughly $2.2 billion a year, from 3,112,056 multiplied by the $697 average fee1, 2. No separate laser hair removal market size exists nationally. Hair removal sits inside the combined laser count, so treat any standalone figure as an estimate.
Dermal filler statistics
Dermal filler statistics describe a paradox. Fillers are the second-largest category by volume and spend, yet demand is contracting. High per-visit value is what keeps the category profitable anyway.
41. Dermal fillers take 20% of US non-surgical patient spending
Dermal fillers take 20% of US non-surgical patient spending, the second-largest category behind neurotoxins, measured at the point of sale5. Toxins and fillers together capture more than half of every dollar the industry earns.
42. An HA filler visit averages $910 in patient spend
An HA filler visit averages $910 in patient spend9. That is more than four times the $216 median med spa ticket12. Filler appointments are the industry’s big-ticket visits, which is why the category’s decline worries operators more than its rank suggests.
43. Biostimulator injectable visits average about $1,280
The per-visit spend ladder
What different med spa visits are worth, measured against the $216 median transaction. Three different measurements are involved, so the bars are grouped by what they actually measure.
Point-of-sale visit averages
Biostimulator injectable visit
$1,280
About 40% above an HA filler visit
5.9× the $216 median transaction
HA filler visit
$910
4.2× the $216 median transaction
Platform transaction data
Transaction, 90th percentile
$484
2.2× the median
Median transaction
$216
Drawn as the reference line every other bar is read against
ASPS physician fee
Neuromodulator treatment
$435
A physician fee, not a point-of-sale ticket
Other booking measures
Polynucleotide booking
$210+
Bookings grew 23% year over year
Skincare add-on, incremental
+$174
Shown floating from $216 to $390, because it is an increment
Lifts total spend by 50% or more
$0$250$500$750$1,000$1,250
The vertical line marks the $216 median transaction. A biostimulator appointment runs almost six times that. The hollow bar is an add-on, not a visit total.
Sources: point-of-sale visit averages (source 9), platform transaction percentiles (source 12), ASPS average physician fee (source 2), polynucleotide bookings (source 19), skincare increment (source 7). These are three different measurements and are not strictly comparable, which is why they are banded.
Biostimulator injectable visits average about $1,280, the highest per-visit spend of any injectable9. Sculptra and Radiesse appointments out-earn HA filler visits by roughly 40%, on a sixth of the volume.
44. The US dermal filler market is worth about $3.8 billion a year
The US dermal filler market size is about $3.8 billion a year in patient spending. The arithmetic: 5,331,426 HA procedures multiplied by the $715 average fee equals $3.81 billion1, 2.
45. A syringe of filler costs $549–$599 at published med spa prices
A syringe of filler costs $549 to $599 at published med spa price lists, and a half syringe about $34923. Most treatments use one to two syringes, which is how a filler visit reaches that $910 average.
46. US Juvederm revenue fell 18% in 2025
US Juvederm revenue fell 18% in 2025, and 26% over two years, even as filler procedure counts held steady14. The market leader’s own filings attribute the drop to decreased consumer demand. Filler statistics rarely come more decisive than an audited 26% two-year slide.
47. US practices log over 3 million lip procedures a year
US practices log over 3 million lip procedures a year across two separately tracked categories1. HA lip augmentation accounts for 1,589,502 and lip augmentation with other injectable materials for 1,449,565. Lip filler statistics keep the two apart to avoid double counting, but together they make lips a category-scale business.
Medical weight loss statistics
Medical weight loss statistics tell the strongest growth story in aesthetics. The numbers below track GLP-1 programs as med spa business data: adoption, new patients, and revenue.
48. Weight-loss treatments grew from 2% of aesthetic spend to 12% in three years
Weight-loss treatments grew from 2% of non-surgical aesthetic spend to 12% in three years6. A six-fold share gain made weight loss the fourth-largest spend category, ahead of professional skincare. No other category has ever moved that fast.
49. About 40% of GLP-1 patients are entirely new to the practice
About 40% of GLP-1 patients are entirely new to the practice they buy from6. Weight loss became an acquisition channel, not just a service line. Patients who arrive for semaglutide convert into neurotoxin, hormone, and skincare clients.
50. 46% of weight-loss patients return, the 2nd-highest retention of any category
46% of weight-loss patients return to the same practice, the second-highest retention of any treatment category6, 10. Only neurotoxins retain better. Monthly dosing builds the habit that most aesthetic treatments have to engineer.
51. 60% of med spas offered GLP-1 by early 2025, versus 35% of physician offices
60% of med spas offered GLP-1 medication by early 2025, against 35% of physician offices6. In the South, med spa adoption hit 70%. Med spas out-adopted the doctors’ offices that were the obvious home for prescription weight loss.
52. GLP-1 adds $15,000–$20,000 in monthly sales to the average practice offering it
GLP-1 programs add $15,000 to $20,000 in monthly sales to the average practice offering them, measured from transaction data6. That is $180,000 to $240,000 a year from a service line that barely existed three years ago.
53. Practices selling GLP-1 grew revenue 9% while those without declined 2%
Weight loss went from 2% of spend to 12% in three years
The fastest-moving category in US aesthetics, shown as share of spend and as practice adoption. The two panels measure different things and keep separate axes.
Share of US aesthetic spend
Weight-loss treatments, percent of total
2%Three years ago12%Today
A six-fold share gain in three years. The article gives the two endpoints only, so no points are drawn between them.
Who offers GLP-1 treatment
Percent of practices, early 2025
Med spas, the South
70%
Highest regional adoption
Med spas, nationally
60%
Physician offices
35%
25 points behind med spas
0%25%50%75%100%
Med spas adopted GLP-1 treatment at nearly twice the rate of physician offices.
What it does to practice revenue
Practices selling GLP-1
+9%
Practices without GLP-1
−2%
An 11-point swing between the two groups
Added monthly sales per practice $15,000–$20,000Which is $180,000–$240,000 a yearPatients entirely new to the practice about 40%
Sources: share of aesthetic spend (source 6), practice adoption and revenue impact (sources 20, 21). The added-sales figure is a published range and is shown as a range, never as a single point estimate. Retention data for weight-loss patients uses a different measure and is not plotted here.
Practices selling GLP-1 grew revenue 9%, while practices without it declined 2%6. An 11-point swing on a single menu decision explains the rush into medical weight loss better than any semaglutide market size projection.
54. Med spas charge $250–$375 a month for compounded semaglutide, while branded self-pay starts at $199
Med spas charge $250 to $375 a month for compounded semaglutide, while the manufacturer’s official Wegovy self-pay price starts at $19922, 23. The branded product now undercuts many compounded programs. Practices betting on weight-loss margins are watching that squeeze closely.
Cosmetic procedure trends
Cosmetic procedure trends run in two directions at once. Injectables and weight loss are climbing, device-led body contouring is collapsing, and audited filings show which is which. These are the med spa industry trends worth planning around.
55. Gen Z’s share of aesthetic patients grew from 4% to 10% in seven years
Gen Z’s share of aesthetic patients grew from 4% to 10% in seven years5. The preventive era has arrived. Patients now start injectables in their twenties, which changes the lifetime value of every new booking.
56. Gen Z aesthetic patients average 2.75 visits per year
Gen Z aesthetic patients average 2.75 visits per year, well above the classic once-or-twice-a-year patient8. The youngest cohort behaves like members rather than occasional buyers.
57. Body contouring spend is down roughly half from its peak
Body contouring spend is down roughly half from its peak, alongside the 40% one-year drop in fat-reduction volume1, 5. GLP-1 medication is replacing device-based fat reduction outright. Among aesthetic industry trends, this is the clearest case of one category eating another.
58. Biostimulator filler spending grew 11% while HA filler spending fell 11%
Biostimulator filler spending grew 11% in a year while HA filler spending fell 11%9. A quiet substitution is running inside injectables, with collagen-stimulating products taking the filler dollar.
59. Aesthetic device sales fell 30% in two years while treatment consumables grew
Practices stopped buying machines, not treating patients
Percent change for the two major aesthetic device makers, split by what they sell. Both companies are on the same percent scale, because only one of them publishes dollar figures for both lines.
Device salesConsumables
InMode
Consumables
+3%
The treatments themselves kept selling
Device sales
−30%
Down 30% over two years
BeautyHealth, maker of Hydrafacial
Consumables
+1.8%
Device sales
−29.7%
No dollar figures published for both lines
Treatment demand is stable. Capital confidence is not. InMode’s device line fell from $412m to $289m in two years while the consumables used on patients kept growing.
Sources: InMode reported results (source 16), BeautyHealth reported results (source 17). BeautyHealth publishes percentages rather than a comparable dollar split, so both companies are compared on percent change and no dollar figures are estimated for BeautyHealth.
Aesthetic device sales at one major manufacturer fell 30% in two years, from $412 million to $289 million, while its consumables revenue grew 3%16. Practices stopped buying machines but kept treating patients. Treatment demand is stable; capital confidence is not.
60. Hydrafacial brings in about 7% of all new med spa patients
Hydrafacial brings in about 7% of all new med spa patients17. Its maker’s consumables revenue grew 1.8% in 2025 while device sales fell 29.7%. Facial volume is holding even as equipment purchases stall, matching the wider device slump.
61. Polynucleotide bookings average over $210 and grew 23% year over year
Polynucleotide injection bookings average over $210 and grew 23% year over year in 2025, the fastest-growing new injectable category on booking platforms19. Regenerative injectables are the trend to watch after toxins and GLP-1.
Average med spa revenue
Average med spa revenue is $1.86 million per location at the median, based on 2025 platform transaction data12. The operational statistics below explain the spread between average and elite better than any treatment menu can.
62. The median med spa generates $1.86 million per location, and the top 10% exceed $4.25 million
The median med spa generates $1.86 million per location a year, and the top 10% exceed $4.25 million, per 2025 transaction data12. That is a 2.3x spread between the middle of the market and the top. The average medical spa revenue question has two honest answers, and the difference between them is operational.
63. The median med spa transaction is $216, rising to $484 at the 90th percentile
The median med spa transaction is $216, rising to $484 at the 90th percentile12. Tickets vary far less than revenue does. The revenue spread comes from volume, not from charging more per visit.
64. Med spas book just 38% of available staff hours at the median, while top performers book 80%
What separates a median med spa from a top performer
Three measures, three panels, three scales. Median and top performer keep the same color in every panel, so the comparison never repaints.
Median med spaTop 10%
Annual revenue
Per location, US dollars
Median
$1.86m
Top 10%
$4.25m+
2.3× the median
A 2.3× spread between the middle of the market and the top.
Average transaction
Per transaction, US dollars
Median
$216
90th pct
$484
$268 above the median
Tickets vary far less than revenue does.
Staff hours booked
Percent of available hours
Median
38%
Top
80%
42 points above the median
Empty chairs, not cheap prices, separate average from elite.
Two operational weak points
13%
of med spa bookings happen online
The lowest of the beauty verticals measured.
5%
no-show rate
The highest of the beauty verticals measured.
Revenue varies by 2.3× while the average ticket varies by far less. The difference is booked hours.
Source: 2025 platform transaction data (source 12). The source does not name the comparison verticals behind the 13% and 5% figures. They are stated in words rather than drawn as bars. Each panel carries its own scale and unit; the three are never combined on one axis.
Med spas book just 38% of available staff hours at the median, while top performers book 80%12. Set a 42-point utilization difference against a $268 ticket difference, and the conclusion writes itself. Empty chairs, not cheap prices, separate average med spa profit from elite.
65. Only 13% of med spa bookings happen online, the lowest of any beauty vertical
Only 13% of med spa bookings happen online at the median practice, the lowest share of any beauty vertical measured12. Med spas also post a 5% no-show rate, the highest of those verticals. For an industry this digital in its marketing, the booking process remains stubbornly analog.
66. Members show 88% higher retention and book 3x as many appointments
Members show 88% higher retention than non-members and book more than three times as many appointments per year20. Med spa membership sales grew another 13% in 202512. No other measured lever moves client lifetime value as far.
67. A professional skincare purchase adds $174 to a visit and lifts total spend by 50% or more
A professional skincare purchase adds $174 to a visit and frequently lifts total per-visit spend by 50% or more7. Skincare attaches to 25% of skin-rejuvenation visits, and buyers were over 10% more likely to return the following year. The smallest item on the menu quietly moves both revenue and retention.
Grow your med spa with Pabau
The greatest losses for med spas come from poorly organized operations. Median med spas book just 38% of staff hours, take only 13% of bookings online, and lose 5% of appointments to no-shows12. Practice management software like Pabau exists to move exactly those numbers.
Online booking lets patients book themselves around the clock, so you capture the demand that phone-only booking turns away. Automated reminders and booking deposits cut no-shows, protecting slots you can’t resell at short notice.
Pabau’s reporting shows each provider’s booked hours, rebooking rate, and revenue, so you can spot empty-chair time before the month ends. Built-in memberships and packages let you run the retention playbook the top earners use. Every feature comes with every subscription, and structured onboarding gets your team confident from day one.
Track the numbers that grow your med spa
Pabau's reports track utilization, rebooking, and no-shows per provider, so you can close the benchmark differences covered above. Online booking and automated reminders fill your calendar while you treat patients.
Conclusion
The treatment menu matters less than the numbers behind it. Counts and revenue tell different stories, and the same service can look dominant on one list while shrinking on the other.
The practices pulling ahead aren’t chasing a magic treatment. They fill their booked hours, rebook patients before they leave, and turn regulars into members. Every benchmark above rewards the same three habits.
Book a demo to see how Pabau helps your med spa track and improve the statistics that decide profit.
Continue your research
Wondering which injectables patients will want next? 14 Botox and filler trends every med spa should know breaks down where treatment demand is heading.
Ready to reprice your treatment menu? How to choose a med spa pricing strategy for profit growth shows how to set prices that protect your margin.
Want more of those 28 million procedures booked with you? Best med spa marketing strategies covers the channels that fill med spa calendars.
Frequently asked questions
What is the most common cosmetic procedure?
Neuromodulator injections such as Botox are the most common cosmetic procedure in the US, at 9,883,711 treatments a year. Hyaluronic acid fillers rank second at 5.3 million.
How many people get Botox a year?
Roughly 5 million Americans get Botox or a similar neurotoxin each year. The US logs 9.88 million procedures, and the average patient books two appointments annually.
What percentage of med spa patients are women?
89% of med spa patients are women, and 54% of female patients are between 35 and 54 years old. Roughly one in 10 patients is a man.
How many people get laser hair removal?
No separate national count exists. Laser hair removal sits within 3.1 million combination laser procedures a year, and it generates more return visits than any other med spa service.
How big is the med spa industry?
The US med spa market size is $20.5 billion in annual non-surgical spending, across more than 11,000 med spas employing over 100,000 people.
How much does the average med spa make?
The median med spa generates $1.86 million per location a year, and the top 10% exceed $4.25 million. Staff utilization, not pricing, drives most of that spread.
Sources
- American Society of Plastic Surgeons (ASPS), 2024 Procedural Statistics, minimally invasive procedure trends
- American Society of Plastic Surgeons (ASPS), Average Surgeon/Physician Fees, 2023 cosmetic procedures report
- US Food and Drug Administration (FDA), product approval records
- Guidepoint Qsight and Skytale Group, joint report on US medical aesthetic non-surgical spend, December 2025
- Guidepoint Qsight, Trends Reshaping the Medical Aesthetics Industry
- Guidepoint Qsight, GLP-1 Report, April 2025
- Guidepoint Qsight, Cross-Purchasing Analytics for Medical Aesthetics
- Guidepoint Qsight, Gen Z aesthetics research, 2025 and 2026
- Guidepoint Qsight, Energy-Based Devices vs Dermal Fillers
- Guidepoint Qsight, The Future of Non-Invasive Aesthetic Treatments
- American Med Spa Association (AmSpa), 2024 Medical Spa State of the Industry Report
- 2026 Beauty and Wellness Benchmark Report, Medspa Edition, with companion industry benchmark data (North American platform transaction records)
- Square, 2023 Beauty and Wellness Trends report, platform data
- AbbVie, Form 10-K for fiscal year 2025, SEC filing
- Evolus, Form 10-K for fiscal year 2025, SEC filing
- InMode, Form 20-F for fiscal year 2025, SEC filing
- BeautyHealth, full-year 2025 financial results and device milestone announcements
- Allergan Aesthetics, Alle loyalty program announcement, April 2026
- 2025 selfcare industry report, global booking marketplace data
- Membership program study from a salon and spa management platform, December 2024
- Centers for Medicare and Medicaid Services, Medicare Part B payment limit file, July 2026
- Novo Nordisk, NovoCare Pharmacy self-pay pricing for Wegovy
- Published price lists from 13 US med spa and laser practices across eight metros, including Milwaukee, Chicago, New York, and Miami
- Regulatory announcements from Evolus, Allergan Aesthetics, AbbVie, and Galderma, 2025 and 2026
